Carrollton, United States
BIOTECH CO. is a groundbreaking company aiming to revolutionize the field of diagnostic solutions for disease prevention, personalized medicine, and comprehensive healthcare advancements. The company was founded in 2010 and is based in China, with its headquarters located in the United States. Led by accomplished professionals from the U.S. diagnostic sector, the company is dedicated to licensing and developing cutting-edge diagnostic products and services.
With a focus on disease prevention, accurate diagnosis, and personalized medicine, BIOTECH CO. is committed to offering a broad spectrum of innovative diagnostic solutions that enhance disease prediction, screening, diagnosis, prognosis, and treatment. Their recent Series A investment on 11 April 2018 was secured from Tasly Pharmaceutical, signifying great confidence and support from significant players in the industry.
Their slogan encapsulates their mission and ambition: "Pioneering innovative diagnostic solutions for disease prevention, personalized medicine, and comprehensive healthcare advancements." As they continue to expand and innovate, BIOTECH CO. stands poised to make a significant impact in the biotechnology sector.
